{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:37:12Z","timestamp":1777599432022,"version":"3.51.4"},"reference-count":58,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cyclosporine is a useful immunosuppressive agent for achieving disease control in moderate to severe atopic dermatitis in children and adults. However, it carries the potential for nephrotoxicity. Monitoring of drug levels is performed in other patient groups, such as transplant recipients, but is not commonplace in the management of atopic dermatitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate levels of nephrotoxicity associated with cyclosporine use in atopic dermatitis and assess potential correlation with trough levels of cyclosporine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An electronic search was conducted on MEDLINE, EMBASE, and Cochrane databases for randomized controlled trials and cohort studies assessing the safety profile of cyclosporine compared to placebo or other atopic dermatitis treatments, in adult and pediatric atopic dermatitis patients from 1966 to May 2019. Studies that did not assess renal toxicity were excluded from analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty\u2010eight trials were included for analysis, excluding 11 that did not assess renal toxicity. Descriptive statistical analysis only was performed, due to the high heterogeneity between study methodologies. Significant renal toxicity was seen in 0%\u20109% of pediatric participants. Monitoring of trough cyclosporine levels was performed in only 10 of the studies, and their correlation to toxicity or disease activity was not explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is limited evidence in atopic dermatitis regarding trough level monitoring of cyclosporine. Currently, the practice is not commonplace, particularly in pediatrics, and this is reflected in trial methodology. Monitoring may be useful in specific pediatric groups, such as those on multiple concurrent medications, patients with hepatic or renal dysfunction and non\u2010responders to therapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pde.13999","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T04:59:47Z","timestamp":1569905987000},"page":"843-853","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review"],"prefix":"10.1111","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1550-168X","authenticated-orcid":false,"given":"Stephanie C.","family":"Blake","sequence":"first","affiliation":[{"name":"Department of Dermatology St George Hospital Sydney NSW Australia"},{"name":"Faculty of Medicine University of New South Wales Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[{"name":"Department of Dermatology St George Hospital Sydney NSW Australia"},{"name":"Faculty of Medicine University of New South Wales Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.251"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.01.778"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02034.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01047.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2003.20617.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.001"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13781"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-018-0788-4"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02023.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12526"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03241.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90281-9"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb00705.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2001.012004216.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12592"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1893-3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14066"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1711-7"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12367"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380220076026"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6549.731"},{"key":"e_1_2_7_23_1","first-page":"34","article-title":"Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?","volume":"13","author":"Tesfaye H","year":"2008","journal-title":"Ann Transplant"},{"key":"e_1_2_7_24_1","first-page":"99","article-title":"Immunosuppressants \u2010 mechanisms of action and monitoring","volume":"29","author":"Pillans P","year":"2006","journal-title":"Exp Clin Pharmacol"},{"key":"e_1_2_7_25_1","first-page":"482","article-title":"The importance of early cyclosporine levels in pediatric kidney transplantation","volume":"10","author":"Matas AJ","year":"1996","journal-title":"Clin Transplant"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.030"},{"key":"e_1_2_7_27_1","unstructured":"EnjetiK.Cyclosporin2018[Available from:https:\/\/www.dermcoll.edu.au\/atoz\/cyclosporin\/. Accessed August 20 2019]."},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14888"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051694"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04836.x"},{"key":"e_1_2_7_31_1","unstructured":"HigginsJPT GreenS.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011].2011. Available athttp:\/\/handbook-5-1.cochrane.org\/Accessed August 20 2019."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80236-1"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb02881.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02936.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb13111.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155501750208137"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb00703.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb00704.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1146.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00976.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018065"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90180-4"},{"key":"e_1_2_7_44_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47102\/annals-acadmedsg.V33N3p311","article-title":"Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study","volume":"33","author":"Lee SS","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.1907.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01877.x"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.1.9"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.027"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.1.158"},{"key":"e_1_2_7_50_1","first-page":"1095","article-title":"Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres","volume":"29","author":"Garritsen FM","year":"2014","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12163"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12374"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13730"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2125"},{"key":"e_1_2_7_55_1","first-page":"802","article-title":"Long\u2010term use of systemic treatments for moderate\u2010to\u2010severe atopic dermatitis in adults: a monocentric retrospective study","volume":"96","author":"Vedie AL","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2689"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08633.x"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1994.tb00895.x"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb03280.x"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.13999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pde.13999","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.13999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:25:57Z","timestamp":1695266757000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.13999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1111\/pde.13999"],"URL":"https:\/\/doi.org\/10.1111\/pde.13999","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"2019-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}